AAPL   383.21 (+0.13%)
MSFT   213.24 (-0.50%)
FB   244.98 (+0.20%)
GOOGL   1,535.85 (+1.13%)
AMZN   3,201.20 (+0.58%)
NVDA   419.71 (-0.15%)
TSLA   1,529.17 (+9.67%)
AMD   55.85 (-2.46%)
T   30.13 (+2.00%)
ACB   11.91 (+1.19%)
F   6.09 (+4.11%)
GILD   76.44 (+2.32%)
DIS   119.18 (+2.02%)
NFLX   547.69 (+7.86%)
BA   178.04 (+2.75%)
AAPL   383.21 (+0.13%)
MSFT   213.24 (-0.50%)
FB   244.98 (+0.20%)
GOOGL   1,535.85 (+1.13%)
AMZN   3,201.20 (+0.58%)
NVDA   419.71 (-0.15%)
TSLA   1,529.17 (+9.67%)
AMD   55.85 (-2.46%)
T   30.13 (+2.00%)
ACB   11.91 (+1.19%)
F   6.09 (+4.11%)
GILD   76.44 (+2.32%)
DIS   119.18 (+2.02%)
NFLX   547.69 (+7.86%)
BA   178.04 (+2.75%)
AAPL   383.21 (+0.13%)
MSFT   213.24 (-0.50%)
FB   244.98 (+0.20%)
GOOGL   1,535.85 (+1.13%)
AMZN   3,201.20 (+0.58%)
NVDA   419.71 (-0.15%)
TSLA   1,529.17 (+9.67%)
AMD   55.85 (-2.46%)
T   30.13 (+2.00%)
ACB   11.91 (+1.19%)
F   6.09 (+4.11%)
GILD   76.44 (+2.32%)
DIS   119.18 (+2.02%)
NFLX   547.69 (+7.86%)
BA   178.04 (+2.75%)
AAPL   383.21 (+0.13%)
MSFT   213.24 (-0.50%)
FB   244.98 (+0.20%)
GOOGL   1,535.85 (+1.13%)
AMZN   3,201.20 (+0.58%)
NVDA   419.71 (-0.15%)
TSLA   1,529.17 (+9.67%)
AMD   55.85 (-2.46%)
T   30.13 (+2.00%)
ACB   11.91 (+1.19%)
F   6.09 (+4.11%)
GILD   76.44 (+2.32%)
DIS   119.18 (+2.02%)
NFLX   547.69 (+7.86%)
BA   178.04 (+2.75%)
Log in

NASDAQ:LMATLeMaitre Vascular Earnings Date, Estimates & History

$25.79
-0.02 (-0.08 %)
(As of 07/10/2020 03:39 PM ET)
Add
Compare
Today's Range
$25.54
Now: $25.79
$25.97
50-Day Range
$23.68
MA: $25.87
$28.22
52-Week Range
$18.76
Now: $25.79
$38.64
Volume1,682 shs
Average Volume136,825 shs
Market Capitalization$520.44 million
P/E Ratio29.64
Dividend Yield1.45%
Beta1.37

Earnings

LeMaitre Vascular (NASDAQ:LMAT) Earnings Information

LeMaitre Vascular last released its earnings data on April 30th, 2020. The medical instruments supplier reported $0.16 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.16. The company earned $30.55 million during the quarter, compared to the consensus estimate of $30.50 million. Its quarterly revenue was up 7.3% compared to the same quarter last year. LeMaitre Vascular has generated $0.88 earnings per share over the last year and currently has a price-to-earnings ratio of 29.6. LeMaitre Vascular has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 22nd, 2020 based off prior year's report dates.

LeMaitre Vascular Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LeMaitre Vascular (NASDAQ:LMAT) Earnings Estimates

2020 EPS Consensus Estimate: $0.94
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202$0.16$0.21$0.19
Q2 20202$0.25$0.25$0.25
Q3 20202$0.22$0.24$0.23
Q4 20202$0.27$0.27$0.27

LeMaitre Vascular (NASDAQ LMAT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
7/22/2020
(Estimated)
       
4/30/2020Q1 2020$0.16$0.16$0.16$30.50 million$30.55 millionTranscript
2/6/2020Q4 2019$0.23$0.23$0.23$30.44 million$30.20 millionTranscript
10/23/2019Q3$0.21$0.25$0.25$28.15 million$29.10 millionTranscript
7/24/2019Q2$0.21$0.23$0.23$28.90 million$29.48 millionListen
5/1/20193/31/2019$0.19$0.17$0.17$27.94 million$28.48 millionN/A
2/19/201912/31/2018$0.24$0.24$0.18$26.06 million$28.39 millionListen
10/5/2018Q3 2018$0.2070$0.2090$0.21$26.06 million$24.17 millionN/A
7/26/2018Q2 2018$0.42$0.21$0.43$27.09 million$27.02 millionTranscript
4/25/2018Q1 2018$0.21$0.19$0.19$26.42 million$25.99 millionN/A
2/21/2018Q4 2017$0.20$0.21$0.21$26.23 million$26.15 millionTranscript
10/26/2017Q3 2017$0.20$0.25$0.25$25.49 million$24.80 millionN/A
7/27/2017Q2 2017$0.17$0.23$0.23$25.42 million$25.80 millionN/A
5/4/2017Q1 2017$0.1310$0.16$0.16$23.48 million$24.10 millionN/A
4/26/2017Q1 2017$0.13$0.16$0.16$23.50 million$24.14 millionN/A
2/21/2017Q4 2016$0.15$0.13$0.13$23.70 million$23.30 millionListen
10/26/2016Q3$0.15$0.17$0.17$22.20 million$19.00 millionListen
7/27/2016Q2$0.11$0.14$0.14$21.59 million$22.40 millionListen
5/2/2016Q1$0.10$0.11$0.11$20.22 million$20.26 millionListen
2/24/2016Q415$0.09$0.13$0.13$20.10 million$20.50 millionListen
10/27/2015Q3$0.0780$0.11$0.11$18.78 million$19.03 millionListen
7/28/2015Q2$0.07$0.10$0.10$18.90 million$19.90 millionListen
4/28/2015Q115$0.05$0.08$0.08$17.76 million$18.90 millionListen
2/25/2015Q314$0.07$0.11$0.11$18.90 million$18.70 millionListen
10/28/2014Q3$0.06$0.05$0.05$17.09 million$17.50 millionListen
7/29/2014Q2 2014$0.05$0.09$0.10$17.57 million$18.16 millionN/A
4/29/2014Q1 2014$0.02$0.02$0.05$16.99 million$16.75 millionN/A
2/25/2014Q4 2013$0.06$0.05$0.05$16.45 million$17.92 millionListen
10/29/2013Q3 2013$0.05$0.05$0.05$15.22 million$15.30 millionListen
7/30/2013Q2 2013$0.04$0.06$0.06$15.42 million$15.95 millionN/A
4/30/2013Q1 2013($0.01)$0.05$0.05$15.00 million$15.38 millionN/A
2/26/2013Q4 2012$0.06$0.03$0.02N/A
10/30/2012Q3 2012$0.04$0.04$0.04N/A
7/31/2012Q2 2012$0.04$0.05$0.05N/A
5/2/2012Q1 2012$0.04$0.02$0.02N/A
2/27/2012Q4 2011$0.06$0.03$0.04N/A
10/27/2011Q3 2011$0.08$0.06$0.04N/A
7/28/2011Q2 2011$0.09$0.06$0.09N/A
4/28/2011Q1 2011$0.06$0.05$0.10N/A
2/28/2011Q4 2010$0.25$0.37N/A
10/28/2010Q3 2010$0.08$0.09$0.09N/A
7/28/2010Q2 2010$0.06$0.09$0.09N/A
4/29/2010Q1 2010$0.05$0.06$0.06N/A
3/4/2010Q4 2009$0.08$0.08N/A
10/28/2009Q3 2009$0.08$0.08N/A
7/29/2009Q2 2009$0.03$0.06$0.06N/A
4/28/2009Q1 2009($0.17)($0.04)$0.04N/A
3/3/2009Q4 2008$0.03$0.04N/A
10/29/2008Q3 2008($0.02)($0.01)($0.01)N/A
7/29/2008Q2 2008($0.04)($0.04)($0.02)N/A
4/30/2008Q1 2008($0.07)($0.12)($0.07)N/A
3/4/2008Q4 2007($0.03)($0.05)($0.02)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.